It will not be fair to run against a woman who has a congenital high level of testosterone. She will have too much of a physiological advantage.
It takes the OLYMPICS-sølvvinderen in the 400 meter hurdles Sara Slott Petersen, referring to the 28-year-old runner Caster Semenya from south Africa.
After the south african runner among other things won the OLYMPIC gold in the 800-meterløb, she come into the media spotlight.
Semenya and other women athletes in the same situation, according to The International Atletikforbund (IAAF) begin to medicate themselves if they have a high level of the male hormone.
they must, if they will continue to run on eliteplan among women.
Slott does not want to compete with a woman like Semenya has a so big advantage on its physics. But at the same time, she looks not that women should tvangsmedicineres.
– It would be so frustrating, and I would consider whether it was fair. We would put the same amount of training and zeal in our participation, but she would still have a big advantage, says Sara Slott Petersen to DR.
– I can well understand that one can look at the sport from the outside and point to all the ethical dilemmas. She has not the right to compete as any other? And of course one must not force people to take medication, they don’t even have the desire to.
The International court of arbitration for sport (CAS) will decide whether the IAAF will be allowed to change the rules from the end of march, or whether Semenya can continue to run as a woman without being tvangsmedicineret.
– It is so severe a case. I know Semenya personally, and she is so sweet. But from a professional point of view, I think she should be allowed to compete against women, says Sara Slott Petersen.
Friday is the last day of the hearing, which is scheduled to last five days. The judgment falls at the end of march.
